PHAT
Phathom Pharmaceuticals Inc

2,364
Mkt Cap
$941.1M
Volume
698,571.00
52W High
$18.31
52W Low
$2.21
PE Ratio
-3.15
PHAT Fundamentals
Price
$12.02
Prev Close
$12.02
Open
$12.20
50D MA
$14.81
Beta
1.27
Avg. Volume
1.36M
EPS (Annual)
-$5.29
P/B
-2.02
Rev/Employee
$129,395.79
$770.68
Loading...
Loading...
News
all
press releases
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Average Recommendation of "Moderate Buy" by Analysts
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering the stock, Marketbeat...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.6% - Here's What Happened
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.6% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Down - Time to Sell?
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap Down - Here's Why...
MarketBeat·1mo ago
News Placeholder
Phathom Pharma Shows Sales Strength, Targets 2026 Profitability
Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue guidance to $174.5-$175.5 million.read more...
Benzinga·1mo ago
News Placeholder
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the stock, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Simplify Asset Management Inc. Reduces Position in Phathom Pharmaceuticals, Inc. $PHAT
Simplify Asset Management Inc. reduced its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 38.3% during the third quarter, according to its most recent filing with the...
MarketBeat·2mo ago
News Placeholder
Notable Monday Option Activity: PHAT, WHR, QBTS
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Phathom Pharmaceuticals Inc (Symbol: PHAT), where a total of 5,492 contracts have traded...
Nasdaq News: Markets·2mo ago
News Placeholder
Raymond James Financial Begins Coverage on Phathom Pharmaceuticals (NASDAQ:PHAT)
Raymond James Financial began coverage on Phathom Pharmaceuticals in a research report on Thursday. They issued a "strong-buy" rating and a $28.00 target price on the stock...
MarketBeat·2mo ago
News Placeholder
Frazier Life Sciences Management L.P. Purchases 2,357,210 Shares of Phathom Pharmaceuticals, Inc. $PHAT
Frazier Life Sciences Management L.P. lifted its holdings in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 23.3% in the 2nd quarter, according to the company in its most...
MarketBeat·2mo ago
News Placeholder
Phathom Pharmaceuticals (NASDAQ:PHAT) Reaches New 12-Month High - What's Next?
Phathom Pharmaceuticals (NASDAQ:PHAT) Hits New 52-Week High - Here's What Happened...
MarketBeat·2mo ago
<
1
2
...
>

Latest PHAT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.